Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07371234 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Neoadjuvant and Adjuvant Immunotherapy
RADIATION: Low-dose radiotherapy
PROCEDURE: Surgery
RADIATION: Adjuvant Radiotherapy
DRUG: Adjuvant Cisplatin

Sponsor

Xiwei XU